Tilray stock price has been highly volatile in the past few months as investors focused on Donald Trump's cannabis reclassification efforts and its implications. It surged from $3.59 in June to a high... ...

Analysts are now focused on the when the change will actually happen, as the cannabis industry waits for tax relief and expanded research opportunities. ...

Core Insights - Tilray Brands is a global leader in the medical cannabis industry, facing competition from major companies like Canopy Growth and Cronos Group [1] Summary by Sections Stock Performance - Bernstein maintained a "Market Perform" rating for Tilray, raising the price target from $1 to $10, while the stock was priced at $12.34 [2] - Despite the hold recommendation, Tilray's stock decreased by 4.2%, closing at $12.34, with trading volume surging to 66.7 million shares, a 514% increase from the three-month average of 10.9 million shares [3][6] - The stock fluctuated between $12.10 and $15.69 during the day, with a market capitalization of approximately $1.38 billion [5] Market Context - The broader market saw gains, with the S&P 500 rising by 0.79% and the Nasdaq Composite increasing by 1.38%, but not all cannabis stocks benefited, indicating market anticipation of the policy change [4][6] - Prior to the executive order reclassifying marijuana, Tilray's stock had surged over 50% due to rumors, which were confirmed by the order [4]

Core Insights - Cannabix Technologies Inc. has launched new product videos for its Marijuana Breath Test (MBT) solution, emphasizing its advanced features and benefits for workplace safety and law enforcement [1][2] - The U.S. Administration's executive order to reclassify marijuana to Schedule III under the Controlled Substances Act highlights the increasing liberalization of cannabis use, creating a demand for Cannabix's MBT solution [1] Product Overview - The MBT system utilizes proprietary Breath Collection Unit and Breath Cartridge technologies to collect and preserve breath samples for analysis using liquid chromatography-mass spectrometry (LC-MS) methods [2] - Cannabix has partnered with Omega Laboratories Inc., a leader in forensic drug testing, to advance the commercialization of the MBT system in the U.S. and Canada [2] Marketing Strategy - The launch of the product videos is a significant step in Cannabix's marketing strategy, providing stakeholders with visuals and key features of the MBT technology [2] - The videos can be accessed through Cannabix's official website, showcasing the technology's role in addressing the need for THC breath detection [2]

VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical-grade cannabis manufacturer, acknowledges the announcement by the United States administration issuing an executive order directing federal agencies to initiate the reclassification of cannabis to a Schedule III controlled substance under U.S. federal law. The executive order directs the relevant federal authorities to advance the administra ...

VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical-grade cannabis manufacturer, acknowledges the announcement by the United States administration issuing an executive order directing federal agencies to initiate the reclassification of cannabis to a Schedule III controlled substance under U.S. federal law. The executive order directs the relevant federal authorities to advance the administra ...

NEW YORK, NY / ACCESS Newswire / December 18, 2025 / The conversation around cannabis reclassification, which was formalized through an executive order signed on Thursday, has focused heavily on policy and capital. Far less attention has been paid to operations. ...

U.S. President Donald Trump said he will direct the U.S. Department of Justice to reclassify cannabis as a less dangerous drug. Here's a look at what that would mean for people shopping at dispensarie... ...

What does classification three actually mean in layman's terms. >> So, under the controlled substances act of 1970, when that was first set up, passed by Congress, signed into law, cannabis was put in schedule one, meaning it is in the same exact schedule drug class as heroin and as LSD. It also means that currently formally, there is no approved medical use or potential medical benefits of cannabis. Moving it to schedule 3 puts it in the same drug class as Tylenol with codine, meaning there is potential me ...

The U.S. labor market showed further signs of cooling in November as nonfarm payrolls rose by 64,000, only modestly above expectations but still weak by historical standards, while the unemployment rate unexpectedly climbed to 4.6%,The Dow Jones Industrial Average fell 0.6% to 48,114.26, while the S&P 500 dropped 0.2% to 6,800.26. The Nasdaq rose 0.2% to 23,111.46.These are the top stocks that gained the attention of retail traders and investors through the day.Tilray Brands Inc. (NASDAQ:TLRY) Tilray Brands ...